Basal Insulins for Type 2 Diabetes

Personalized education in 30-60 minutes at a time that is convenient for you. This Group Learning program has been certified by the College of Family Physicians of Canada for up to 2.0 Mainpro+ credits.

Learning Objective

Participants will be able to assess a patient’s risk for hypoglycemia and confidently make adjustments to glucose lowering therapy to minimize the risk.

During the academic detailing visit, participants will have the opportunity to discuss:

• Evidence for the comparative hypoglycemia risk of basal insulins and medication costs for people with type 2 diabetes
• Relevant clinical considerations when prescribing and monitoring basal insulin therapy for people with type 2 diabetes
• How different guidelines weigh the value of intensifying glucose-lowering medications to achieve tight glycemic control in people with type 2 diabetes

After the academic detailing visit and completion of the Reflection Activity, participants will be able to:

1. Compare hypoglycemic risk between the basal insulins.
2. Adjust a patient’s glucose lowering therapy to reduce the risk of hypoglycemia.
3. Write insulin prescriptions to minimize the risk for error.
4. Ensure insulin therapy (and associated supplies) are affordable and manageable for patients.

Availability

When: Until December 5, 2020
Where: Via 'virtual detailing' (Individualized Web or Teleconference)
How: Email pad@gov.bc.ca or Phone 604-398-5918

Resources

• Appendix: SGLT2 Inhibitors and Diabetic Ketoacidosis (PDF, 381KB)
• Basal Insulins for Type 2 Diabetes: How does insulin choice affect the risk of hypoglycemia and medication cost?
• References
• Supplement
• Supplement References

For more information about the PAD service, visit PAD Frequently Asked Questions